HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 2418789Erstellt: 27. Oktober 2026
4-Ethyl-4-hydroxy-9-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione → 10-Aminocamptothecin
https://huagongshe.com/reaction/2418789
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 4-Ethyl-4-hydroxy-9-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | HCID 65567 | — |
| Edukt | Tin atom | HCID 5352426 | — |
| Katalysator | Iron | HCID 23925 | — |
| Katalysator | Zinc | HCID 23994 | — |
| Lösungsmittel | Platinum oxide (PtO) | HCID 82844 | — |
| Produkt | 10-Aminocamptothecin | HCID 104986 | — |
Reaktionsschritte
In order to obtain the product of the general formula (I') wherein R3' is an amino group, 10-nitrocamptothecin, its tetrahydro derivative or its 1-acyl-tetrahydro derivative is subjected to a conventional reductive reaction contemplated for reducing a nitro group to an amino group. Usually, Clemensen' reduction method (a combination of dilute mineral acid and tin, iron or zinc) or a catalytic reduction method is used for this purpose. Advantageously, 10-nitrocamptothecin is dissolved in a solvent and hydrogenated at room temperature under atmospheric pressure in the presence of a small amount of platinum oxide. In this case, the desired 10-aminocamptothecin can be obtained by removing the catalyst from the reaction mixture by filtration and evaporating the solvent under reduced pressure.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US04473692 |
|---|
| Quelldatensatz | uspto-grants-1984_09 |
|---|
| ORD ID | ord-3c1640547f49477aa5e96b214bd06609 |
|---|
| Quellennotiz | uspto-grants-1984_09 |
|---|